Monitoring mTOR activation over time could help determine whether its upregulation in GDM-I placentas is an early compensatory response to insulin resistance or a progressive adaptation that exacerbates fetal overgrowth [12]. The gene discussed is MTOR; the disease is Insulin resistance.